Skip to main content
Top
Published in: Endocrine 2/2015

01-06-2015 | Original Article

Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population

Authors: Wen-Jun Wei, Yu-Long Wang, Duan-Shu Li, Yu Wang, Xiao-feng Wang, Yong-Xue Zhu, Xue-Dong Pan, Zhuo-Ying Wang, Yi Wu, Li Jin, Jiu-Cun Wang, Qing-Hai Ji

Published in: Endocrine | Issue 2/2015

Login to get access

Abstract

MicroRNAs (miRNAs) are small non-coding RNA molecules that are involved in a variety of cellular functions. Single nucleotide polymorphisms (SNPs) have been identified in mature miRNAs (mmSNPs), some of which have been linked to cancer risk; however, it is unclear which mmSNPs contribute to the susceptibility to thyroid tumors. In the present study, we examined the influence of selected mmSNPs on the risk of thyroid tumor. After systematic in silico screening, seventeen mmSNPs were identified and genotyped in a Chinese population including 828 patients with papillary thyroid cancer (PTC), 488 patients with benign thyroid tumor (BN), and 1038 cancer-free controls. Multivariate logistic regression analyses were conducted to evaluate the association of SNP genotypes and alleles with the risk of developing PTC and BN. Three SNPs (rs67106263 in mir-3144, GA versus GG, OR = 1.35, 1.09–1.68; rs4919510 in mir-608, CC versus GG/GC, OR = 0.76, 0.60–0.97; and rs79402775 in mir-933, AA versus GG/GA, OR = 1.76, 1.00–3.12) were associated with PTC risk. A combined effect of unfavorable genotypes was observed to give increased PTC risk in a dose-dependent manner. In addition, three SNPs (rs10061133 in mir-449b, rs79402775 in mir-933 and rs4919510 in mir-608) showed at least borderline correlations with the risk of BN. False-positive report probability was assessed for significant findings. The rs67106263 SNP was associated with the expression level of mir-3144 in thyroid tissue. These results indicate that mmSNPs may contribute to genetic susceptibility to thyroid tumors. Large validation and functional studies are required to further explore the role of mmSNPs in carcinogenesis.
Appendix
Available only for authorised users
Literature
1.
3.
go back to reference M. Fallah, E. Pukkala, L. Tryggvadottir, J.H. Olsen, S. Tretli, K. Sundquist, K. Hemminki, Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J. Med. Genet. 50, 373–382 (2013)CrossRefPubMed M. Fallah, E. Pukkala, L. Tryggvadottir, J.H. Olsen, S. Tretli, K. Sundquist, K. Hemminki, Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J. Med. Genet. 50, 373–382 (2013)CrossRefPubMed
4.
go back to reference E. Adjadj, M. Schlumberger, F. de Vathaire, Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol. 10, 181–190 (2009)CrossRefPubMed E. Adjadj, M. Schlumberger, F. de Vathaire, Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol. 10, 181–190 (2009)CrossRefPubMed
5.
go back to reference J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, A. Sigurdsson, J.T. Bergthorsson, H. He, T. Blondal, F. Geller, M. Jakobsdottir, D.N. Magnusdottir, S. Matthiasdottir, S.N. Stacey, O.B. Skarphedinsson, H. Helgadottir, W. Li, R. Nagy, E. Aguillo, E. Faure, E. Prats, B. Saez, M. Martinez, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, K. Kristjansson, M.L. Frigge, H. Kristvinsson, J.R. Gulcher, T. Jonsson, T. Rafnar, H. Hjartarsson, J.I. Mayordomo, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, A. Kong, K. Stefansson, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41, 460–464 (2009)CrossRefPubMedCentralPubMed J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, A. Sigurdsson, J.T. Bergthorsson, H. He, T. Blondal, F. Geller, M. Jakobsdottir, D.N. Magnusdottir, S. Matthiasdottir, S.N. Stacey, O.B. Skarphedinsson, H. Helgadottir, W. Li, R. Nagy, E. Aguillo, E. Faure, E. Prats, B. Saez, M. Martinez, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, K. Kristjansson, M.L. Frigge, H. Kristvinsson, J.R. Gulcher, T. Jonsson, T. Rafnar, H. Hjartarsson, J.I. Mayordomo, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, A. Kong, K. Stefansson, Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41, 460–464 (2009)CrossRefPubMedCentralPubMed
6.
go back to reference J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, G. Masson, H. He, A. Jonasdottir, A. Sigurdsson, S.N. Stacey, H. Johannsdottir, H.T. Helgadottir, W. Li, R. Nagy, M.D. Ringel, R.T. Kloos, M.C. de Visser, T.S. Plantinga, M. den Heijer, E. Aguillo, A. Panadero, E. Prats, A. Garcia-Castano, A. De Juan, F. Rivera, G.B. Walters, H. Bjarnason, L. Tryggvadottir, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, I. Olafsson, K. Kristjansson, H. Kristvinsson, O.T. Magnusson, G. Thorleifsson, J.R. Gulcher, A. Kong, L.A. Kiemeney, T. Jonsson, H. Hjartarson, J.I. Mayordomo, R.T. Netea-Maier, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, T. Rafnar, K. Stefansson, Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44, 319–322 (2012)CrossRefPubMedCentralPubMed J. Gudmundsson, P. Sulem, D.F. Gudbjartsson, J.G. Jonasson, G. Masson, H. He, A. Jonasdottir, A. Sigurdsson, S.N. Stacey, H. Johannsdottir, H.T. Helgadottir, W. Li, R. Nagy, M.D. Ringel, R.T. Kloos, M.C. de Visser, T.S. Plantinga, M. den Heijer, E. Aguillo, A. Panadero, E. Prats, A. Garcia-Castano, A. De Juan, F. Rivera, G.B. Walters, H. Bjarnason, L. Tryggvadottir, G.I. Eyjolfsson, U.S. Bjornsdottir, H. Holm, I. Olafsson, K. Kristjansson, H. Kristvinsson, O.T. Magnusson, G. Thorleifsson, J.R. Gulcher, A. Kong, L.A. Kiemeney, T. Jonsson, H. Hjartarson, J.I. Mayordomo, R.T. Netea-Maier, A. de la Chapelle, J. Hrafnkelsson, U. Thorsteinsdottir, T. Rafnar, K. Stefansson, Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44, 319–322 (2012)CrossRefPubMedCentralPubMed
7.
go back to reference M.R. Vriens, I. Suh, W. Moses, E. Kebebew, Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19, 1343–1349 (2009)CrossRefPubMed M.R. Vriens, I. Suh, W. Moses, E. Kebebew, Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid 19, 1343–1349 (2009)CrossRefPubMed
8.
9.
go back to reference J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, T.R. Golub, MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005)CrossRefPubMed J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, T.R. Golub, MicroRNA expression profiles classify human cancers. Nature 435, 834–838 (2005)CrossRefPubMed
10.
go back to reference Z. Hu, X. Chen, Y. Zhao, T. Tian, G. Jin, Y. Shu, Y. Chen, L. Xu, K. Zen, C. Zhang, H. Shen, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721–1726 (2010)CrossRefPubMed Z. Hu, X. Chen, Y. Zhao, T. Tian, G. Jin, Y. Shu, Y. Chen, L. Xu, K. Zen, C. Zhang, H. Shen, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721–1726 (2010)CrossRefPubMed
11.
go back to reference J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P.S. Meltzer, C.M. Croce, L.X. Qin, K. Man, C.M. Lo, J. Lee, I.O. Ng, J. Fan, Z.Y. Tang, H.C. Sun, X.W. Wang, MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361, 1437–1447 (2009)CrossRefPubMedCentralPubMed J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen, P.S. Meltzer, C.M. Croce, L.X. Qin, K. Man, C.M. Lo, J. Lee, I.O. Ng, J. Fan, Z.Y. Tang, H.C. Sun, X.W. Wang, MicroRNA expression, survival, and response to interferon in liver cancer. N. Engl. J. Med. 361, 1437–1447 (2009)CrossRefPubMedCentralPubMed
12.
13.
go back to reference B.M. Ryan, A.I. Robles, C.C. Harris, Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 10, 389–402 (2010)CrossRefPubMedCentralPubMed B.M. Ryan, A.I. Robles, C.C. Harris, Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 10, 389–402 (2010)CrossRefPubMedCentralPubMed
14.
go back to reference Z. Hu, J. Chen, T. Tian, X. Zhou, H. Gu, L. Xu, Y. Zeng, R. Miao, G. Jin, H. Ma, Y. Chen, H. Shen, Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118, 2600–2608 (2008)PubMedCentralPubMed Z. Hu, J. Chen, T. Tian, X. Zhou, H. Gu, L. Xu, Y. Zeng, R. Miao, G. Jin, H. Ma, Y. Chen, H. Shen, Genetic variants of miRNA sequences and non-small cell lung cancer survival. J. Clin. Invest. 118, 2600–2608 (2008)PubMedCentralPubMed
15.
go back to reference Z. Hu, J. Liang, Z. Wang, T. Tian, X. Zhou, J. Chen, R. Miao, Y. Wang, X. Wang, H. Shen, Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30, 79–84 (2009)CrossRefPubMed Z. Hu, J. Liang, Z. Wang, T. Tian, X. Zhou, J. Chen, R. Miao, Y. Wang, X. Wang, H. Shen, Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum. Mutat. 30, 79–84 (2009)CrossRefPubMed
16.
go back to reference T. Tian, Y. Shu, J. Chen, Z. Hu, L. Xu, G. Jin, J. Liang, P. Liu, X. Zhou, R. Miao, H. Ma, Y. Chen, H. Shen, A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18, 1183–1187 (2009)CrossRefPubMed T. Tian, Y. Shu, J. Chen, Z. Hu, L. Xu, G. Jin, J. Liang, P. Liu, X. Zhou, R. Miao, H. Ma, Y. Chen, H. Shen, A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol. Biomarkers Prev. 18, 1183–1187 (2009)CrossRefPubMed
17.
go back to reference M. Okubo, T. Tahara, T. Shibata, H. Yamashita, M. Nakamura, D. Yoshioka, J. Yonemura, T. Ishizuka, T. Arisawa, I. Hirata, Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15, 524–531 (2010)CrossRefPubMed M. Okubo, T. Tahara, T. Shibata, H. Yamashita, M. Nakamura, D. Yoshioka, J. Yonemura, T. Ishizuka, T. Arisawa, I. Hirata, Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15, 524–531 (2010)CrossRefPubMed
18.
go back to reference Z. Liu, G. Li, S. Wei, J. Niu, A.K. El-Naggar, E.M. Sturgis, Q. Wei, Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116, 4753–4760 (2010)CrossRefPubMedCentralPubMed Z. Liu, G. Li, S. Wei, J. Niu, A.K. El-Naggar, E.M. Sturgis, Q. Wei, Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116, 4753–4760 (2010)CrossRefPubMedCentralPubMed
19.
go back to reference W.H. Kim, K.T. Min, Y.J. Jeon, C.I. Kwon, K.H. Ko, P.W. Park, S.P. Hong, K.S. Rim, S.W. Kwon, S.G. Hwang, N.K. Kim, Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 504, 92–97 (2012)CrossRefPubMed W.H. Kim, K.T. Min, Y.J. Jeon, C.I. Kwon, K.H. Ko, P.W. Park, S.P. Hong, K.S. Rim, S.W. Kwon, S.G. Hwang, N.K. Kim, Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Gene 504, 92–97 (2012)CrossRefPubMed
20.
go back to reference K. Jazdzewski, E.L. Murray, K. Franssila, B. Jarzab, D.R. Schoenberg, A. de la Chapelle, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U.S.A. 105, 7269–7274 (2008)CrossRefPubMedCentralPubMed K. Jazdzewski, E.L. Murray, K. Franssila, B. Jarzab, D.R. Schoenberg, A. de la Chapelle, Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U.S.A. 105, 7269–7274 (2008)CrossRefPubMedCentralPubMed
21.
go back to reference A.M. Jones, K.M. Howarth, L. Martin, M. Gorman, R. Mihai, L. Moss, A. Auton, C. Lemon, H. Mehanna, H. Mohan, S.E. Clarke, J. Wadsley, E. Macias, A. Coatesworth, M. Beasley, T. Roques, C. Martin, P. Ryan, G. Gerrard, D. Power, C. Bremmer, I. Tomlinson, L.G. Carvajal-Carmona, Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J. Med. Genet. 49, 158–163 (2012)CrossRefPubMedCentralPubMed A.M. Jones, K.M. Howarth, L. Martin, M. Gorman, R. Mihai, L. Moss, A. Auton, C. Lemon, H. Mehanna, H. Mohan, S.E. Clarke, J. Wadsley, E. Macias, A. Coatesworth, M. Beasley, T. Roques, C. Martin, P. Ryan, G. Gerrard, D. Power, C. Bremmer, I. Tomlinson, L.G. Carvajal-Carmona, Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J. Med. Genet. 49, 158–163 (2012)CrossRefPubMedCentralPubMed
22.
go back to reference X. Wang, M. Lu, J. Qian, Y. Yang, S. Li, D. Lu, S. Yu, W. Meng, W. Ye, L. Jin, Rationales, design and recruitment of the Taizhou Longitudinal Study. Bmc Public Health 9, 223 (2009)CrossRefPubMedCentralPubMed X. Wang, M. Lu, J. Qian, Y. Yang, S. Li, D. Lu, S. Yu, W. Meng, W. Ye, L. Jin, Rationales, design and recruitment of the Taizhou Longitudinal Study. Bmc Public Health 9, 223 (2009)CrossRefPubMedCentralPubMed
23.
go back to reference G.R. Abecasis, A. Auton, L.D. Brooks, M.A. DePristo, R.M. Durbin, R.E. Handsaker, H.M. Kang, G.T. Marth, G.A. McVean, An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012)CrossRefPubMed G.R. Abecasis, A. Auton, L.D. Brooks, M.A. DePristo, R.M. Durbin, R.E. Handsaker, H.M. Kang, G.T. Marth, G.A. McVean, An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012)CrossRefPubMed
24.
25.
go back to reference C. Jurinke, D. van den Boom, C.R. Cantor, H. Koster, Automated genotyping using the DNA mass array technology. Methods Mol. Biol. 187, 179–192 (2002)PubMed C. Jurinke, D. van den Boom, C.R. Cantor, H. Koster, Automated genotyping using the DNA mass array technology. Methods Mol. Biol. 187, 179–192 (2002)PubMed
26.
go back to reference S. Wacholder, S. Chanock, M. Garcia-Closas, G.L. El, N. Rothman, Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96, 434–442 (2004)CrossRefPubMed S. Wacholder, S. Chanock, M. Garcia-Closas, G.L. El, N. Rothman, Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl Cancer Inst. 96, 434–442 (2004)CrossRefPubMed
27.
go back to reference H. Yang, C.P. Dinney, Y. Ye, Y. Zhu, H.B. Grossman, X. Wu, Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 68, 2530–2537 (2008)CrossRefPubMed H. Yang, C.P. Dinney, Y. Ye, Y. Zhu, H.B. Grossman, X. Wu, Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res. 68, 2530–2537 (2008)CrossRefPubMed
28.
go back to reference A.J. Huang, K.D. Yu, J. Li, L. Fan, Z.M. Shao, Polymorphism rs4919510:C > G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes. PLoS One 7, e35252 (2012)CrossRefPubMedCentralPubMed A.J. Huang, K.D. Yu, J. Li, L. Fan, Z.M. Shao, Polymorphism rs4919510:C > G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes. PLoS One 7, e35252 (2012)CrossRefPubMedCentralPubMed
29.
go back to reference B.M. Ryan, A.C. McClary, N. Valeri, D. Robinson, A. Paone, E.D. Bowman, A.I. Robles, C. Croce, C.C. Harris, rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One 7, e36306 (2012)CrossRefPubMedCentralPubMed B.M. Ryan, A.C. McClary, N. Valeri, D. Robinson, A. Paone, E.D. Bowman, A.I. Robles, C. Croce, C.C. Harris, rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer. PLoS One 7, e36306 (2012)CrossRefPubMedCentralPubMed
30.
go back to reference K. Jazdzewski, S. Liyanarachchi, M. Swierniak, J. Pachucki, M.D. Ringel, B. Jarzab, A. de la Chapelle, Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc. Natl. Acad. Sci. USA 106, 1502–1505 (2009)CrossRefPubMedCentralPubMed K. Jazdzewski, S. Liyanarachchi, M. Swierniak, J. Pachucki, M.D. Ringel, B. Jarzab, A. de la Chapelle, Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc. Natl. Acad. Sci. USA 106, 1502–1505 (2009)CrossRefPubMedCentralPubMed
Metadata
Title
Association study of single nucleotide polymorphisms in mature microRNAs and the risk of thyroid tumor in a Chinese population
Authors
Wen-Jun Wei
Yu-Long Wang
Duan-Shu Li
Yu Wang
Xiao-feng Wang
Yong-Xue Zhu
Xue-Dong Pan
Zhuo-Ying Wang
Yi Wu
Li Jin
Jiu-Cun Wang
Qing-Hai Ji
Publication date
01-06-2015
Publisher
Springer US
Published in
Endocrine / Issue 2/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0467-8

Other articles of this Issue 2/2015

Endocrine 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.